918514-78-0 Usage
General Description
2-(trifluoromethyl)-1H-pyrrolo[2,3-b]pyridine is a chemical compound with a molecular formula C8H5F3N2. It is a heterocyclic compound that contains a pyrrole ring fused to a pyridine ring, and it also has a trifluoromethyl group attached to the pyrrole ring. 2-(trifluoromethyl)-1H-pyrrolo[2,3-b]pyridine is commonly used in organic synthesis and medicinal chemistry as a building block for creating various molecules and pharmaceuticals. It possesses unique physicochemical properties due to the presence of the trifluoromethyl group, making it a valuable tool for drug discovery and development. Additionally, the trifluoromethyl group can enhance the biological activity and metabolic stability of drug candidates, making this compound an important constituent in the design and development of new drugs.
Check Digit Verification of cas no
The CAS Registry Mumber 918514-78-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,8,5,1 and 4 respectively; the second part has 2 digits, 7 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 918514-78:
(8*9)+(7*1)+(6*8)+(5*5)+(4*1)+(3*4)+(2*7)+(1*8)=190
190 % 10 = 0
So 918514-78-0 is a valid CAS Registry Number.
918514-78-0Relevant articles and documents
Metal-free oxidative trifluoromethylation of indoles with CF3SO2Na on the C2 position
Xie, Jiao-Jiao,Wang, Zhi-Qing,Jiang, Guo-Fang
, p. 35098 - 35101 (2019/11/14)
An efficient method of synthesizing 2-trifluoromethylindoles from indoles with easy-to-handle, cheap and low-toxic CF3SO2Na under metal-free conditions is described, which selectively introduces trifluoromethyl to indoles on the C2 position. The desired product can be obtained in 0.7 g yield. A radical intermediate may be involved in this transformation.
Azaquinazoline Inhibitors Of Atypical Protein Kinase C
-
Paragraph 0228, (2015/12/24)
The present application provides a compound of formula (I) and/or a salt thereof, wherein R1, G, and X are as defined herein. A compound of formula (I) and/or its salts have aPKC inhibitory activity, and may be used to treat proliferative disor
NOVEL COMPOUNDS
-
, (2009/01/20)
The invention is directed to certain novel compounds. Specifically, the invention is directed to compounds according to formula (I) and salts thereof. The compounds of the invention are inhibitors of kinase activity, in particular IKK2 activity.